Skip to main content
KMTS logo

Kestra Medical Technologies, Ltd.

KMTSNASDAQHealthcareMedical Instruments & Supplies

$29.42Today:- (-)1Y +10.24%

As of Oct 26, 2026 close

Market cap
$1.72B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$17.34$30.00
Volume (live)
-
Avg. volume (3M)
428.78K

Kestra Medical Technologies (KMTS) Balance Sheet

As of Apr 30, 2026 (end of fiscal 2026), Kestra Medical Technologies reported total assets of $358.46M and total liabilities of $98.81M. Shareholders' equity was $259.66M, up 26.4% from $205.41M a year earlier. Total debt stood at $46.79M against $196.43M in cash and short-term investments, a net cash position of $149.64M. That puts debt-to-equity at 0.18, compared with 0.20 a year earlier.

Kestra Medical Technologies Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Kestra Medical Technologies, Ltd. (KMTS) - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2021FY 2020
Period endingApr 2026Apr 2025Apr 2024Apr 2023Apr 2021Apr 2020
Current Assets
Cash and Cash Equivalents99.71237.608.2514.8124.345.76
Short-Term Investments96.720.000.000.000.000.00
Cash & Short-Term Investments196.43237.608.2514.8124.345.76
Accounts Receivable14.548.082.002.000.000.00
Inventory6.716.573.292.110.000.00
Other Current Assets4.681.690.421.371.350.41
Total Current Assets222.36255.3314.9118.4226.206.17
Non-Current Assets
Property, Plant & Equipment (Net)62.4536.9128.3928.393.081.13
Long-Term Investments65.770.000.000.000.000.00
Other Non-Current Assets7.891.490.942.651.240.58
Total Non-Current Assets136.1140.4231.0420.234.331.71
Total Assets358.47295.7445.9538.6630.527.87
Current Liabilities
Accounts Payable27.3023.9623.8923.891.701.83
Short-Term Debt0.030.370.0020.451.060.45
Current Portion of Long-Term Debt---20.45--
Accrued Liabilities9.115.162.899.083.811.73
Other Current Liabilities23.0513.644.555.383.811.67
Total Current Liabilities50.3737.9832.9732.976.614.02
Non-Current Liabilities
Long-Term Debt46.7641.1042.5442.5420.240.00
Other Non-Current Liabilities1.680.140.080.080.360.00
Total Non-Current Liabilities48.4352.36222.3645.2522.150.00
Total Liabilities98.8190.34255.3354.1228.764.02
Stockholders' Equity
Common Stock58.3851.3519.9119.910.000.00
Retained Earnings-651.86-520.25-406.44-406.44-170.08-135.98
Accumulated Other Comprehensive Income-0.220.000.000.000.000.00
Additional Paid-in Capital853.35674.31177.15194.74171.85139.84
Shares Outstanding58.3851.3549.5349.5349.53-
Total Stockholders' Equity259.66205.41-209.38-15.471.773.86
Total Liabilities & Equity358.47295.7445.9538.6630.527.87

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Kestra Medical Technologies Balance Sheet

How much debt does Kestra Medical Technologies have?

Kestra Medical Technologies had total debt of $46.79M as of Apr 30, 2026, against $196.43M in cash and short-term investments. Its debt-to-equity ratio was 0.18. Total debt was $41.47M a year earlier.

What are Kestra Medical Technologies's total assets?

Kestra Medical Technologies reported total assets of $358.46M as of Apr 30, 2026, up 21.2% from $295.74M a year earlier. Total liabilities were $98.81M.

What is Kestra Medical Technologies's shareholders' equity?

Kestra Medical Technologies's shareholders' equity was $259.66M as of Apr 30, 2026, or about $4.45 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition